FOR46
Showing 26 - 50 of >10,000
Stroke Trial in Sweden (Mobile phone supported and team based rehabilitation, Rehabilitation as usual)
Recruiting
- Stroke
- Mobile phone supported and team based rehabilitation
- Rehabilitation as usual
-
Stockholm, Bromma, Sweden
- +11 more
Jun 27, 2022
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Tumor Lysis Syndrome Trial in Houston (Pegloticase, Rasburicase)
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jun 29, 2022
Cognitive Changes Associated With Breast Cancer Treatment
Completed
- Breast Cancer
- +2 more
- Questionnaires, MRI, Comet assay and Cell senescence
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Dec 29, 2021
Intrauterine Fetal Demise, Fetal Death Trial in Bronx (Mifepristone, )
Terminated
- Intrauterine Fetal Demise
- Fetal Death
- Mifepristone
- placebo
-
Bronx, New YorkMontefiore Medical Center
Jan 30, 2021
Healthy Volunteers Trial in United Kingdom (TDV, HAV Vaccine, TDV Placebo)
Completed
- Healthy Volunteers
- TDV
- +3 more
-
Edgbaston, Birmingham, United Kingdom
- +9 more
Aug 17, 2022
DuraLock-C Catheter Lock Solution
Not yet recruiting
- Hemodialysis Catheter Patency
- Locking Solution
- (no location specified)
Mar 4, 2021
Cardiovascular Disease Trial in Madrid (PSIE13, PSIE46)
Completed
- Cardiovascular Disease
- PSIE13
- PSIE46
-
Madrid, SpainFoundation for Science, Health and Education
Feb 1, 2021
Excessive Bleeding During Surgery Trial in Worldwide (Fibrin Sealant Grifols, EVICEL)
Completed
- Excessive Bleeding During Surgery
- Fibrin Sealant Grifols
- EVICEL
-
Houston, Texas
- +13 more
May 26, 2022
Glabellar Lines, Lateral Canthal Lines Trial in Worldwide (MT10109L, Placebo)
Completed
- Glabellar Lines
- Lateral Canthal Lines
- MT10109L
- Placebo
-
Glendale, Arizona
- +20 more
Sep 2, 2022
Detection of Delayed Adverse Events in Cal-1 Recipients
Active, not recruiting
- HIV-1 Infection
- Receipt of Cal-1 Modified Hematopoietic Cellular Products
- Blood tests
-
Los Angeles, California
- +1 more
Feb 3, 2021
Carcinosarcoma, Endometrial Tumors Trial in United Kingdom (Paclitaxel, Cediranib, Olaparib)
Active, not recruiting
- Carcinosarcoma
- Endometrial Neoplasms
- Paclitaxel
- +2 more
-
Northwood, Middlesex, United Kingdom
- +14 more
Feb 10, 2022
Body Dysmorphic Disorders Trial in Stockholm (I-CBT for Body Dysmorphic Disorder)
Completed
- Body Dysmorphic Disorders
- I-CBT for Body Dysmorphic Disorder
-
Stockholm, Huddinge, SwedenM46: Karolinska Universitetssjukhuset, Psykiatri Sydväst
Sep 14, 2020
Osteoarthritis, Knee, Osteoarthritis, Hip Trial in Poland, United Kingdom, United States (Fasinumab, Naproxen, Diclofenac)
Terminated
- Osteoarthritis, Knee
- Osteoarthritis, Hip
- Fasinumab
- +4 more
-
Phoenix, Arizona
- +14 more
Aug 24, 2021
Myocardial Infarction Trial in Worldwide (Tenecteplase, Clopidogrel, Coronary angiography)
Active, not recruiting
- Myocardial Infarction
- Tenecteplase
- +3 more
-
Liverpool, Australia
- +49 more
Dec 20, 2022
Utilisation of Nuwiq, Octanate and Wilate in Previously
Recruiting
- Haemophilia A
-
Las Vegas, Nevada
- +33 more
Jul 7, 2022
Essential Hypertension Trial in Russian Federation (Amlodipine 5mg + bisoprolol fumarate 5mg + perindopril arginine 5mg, Norvasc
Completed
- Essential Hypertension
- Amlodipine 5mg + bisoprolol fumarate 5mg + perindopril arginine 5mg
- +3 more
-
Barnaul, Altai Region, Russian Federation
- +14 more
Aug 3, 2022
Atopic Dermatitis Eczema Trial in Canada, United States (ARQ-151 Cream 0.15% or ARQ-151 Cream 0.05%)
Recruiting
- Atopic Dermatitis Eczema
- ARQ-151 Cream 0.15% or ARQ-151 Cream 0.05%
-
Birmingham, Alabama
- +91 more
Jan 26, 2023
Colon Cancer, Rectal Cancer Trial in Pawtucket, Providence (drug, radiation, procedure)
Haemophilia A and B With and Without Inhibitors Trial in Worldwide (Concizumab)
Recruiting
- Haemophilia A and B With and Without Inhibitors
-
San Diego, California
- +55 more
Feb 2, 2023
Nasopharyngeal Carcinoma Trial in Worldwide (autologous EBV specific Cytotoxic T cells, combination IV gemcitabine and IV
Active, not recruiting
- Nasopharyngeal Carcinoma
- autologous EBV specific Cytotoxic T cells
- combination IV gemcitabine and IV carboplatin (AUC2)
-
Duarte, California
- +29 more
Mar 5, 2021
Amyotrophic Lateral Sclerosis Trial in Worldwide (SAR443820, Placebo)
Recruiting
- Amyotrophic Lateral Sclerosis
- SAR443820
- Placebo
-
La Jolla, California
- +54 more
Feb 1, 2023
Schizophrenia Trial in Worldwide (SEP-363856 75mg, SEP-363856 100mg, Placebo)
Recruiting
- Schizophrenia
- SEP-363856 75mg
- +2 more
-
Little Rock, Arkansas
- +63 more
Dec 12, 2022